Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Feasibility and Safety of Using Nasal High Flow Oxygen for Five Days Postoperatively to Reduce Respiratory Complications After Oesophagectomy for Cancer

NCT04272268 is registered in ClinicalTrials.gov with University Hospitals of North Midlands NHS Trust as lead sponsor.

NCT NCT04272268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04272268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Feasibility and Safety of Using Nasal High Flow Oxygen for Five Days Postoperatively to Reduce Respiratory Complications After Oesophagectomy for Cancer
Lead sponsor
University Hospitals of North Midlands NHS Trust
Phase
Observational
Overall status
Withdrawn
Start date
October 1, 2019
Completion date
March 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the esophagus